SLC1A2

SLC1A2

SLC1A2 Informations sur la molécule

Molecule Name
Excitatory amino acid transporter 2
Alias de la molécule
DEE41, EAAT2, EIEE41, GLT-1, GLT1, HBGT
Drug Development Progress
Nombre de médicaments cliniques2
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
GLT1,Glutamate/aspartate transporter II,Sodium-dependent glutamate/aspartate transporter 2,Solute carrier family 1 member 2,SLC1A2,EAAT2
Contexte de la molécule
This gene encodes a member of a family of solute transporter proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. Improper regulation of this gene is thought to be associated with several neurological disorders. Alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Jun 2017]

SLC1A2 Liste de produits

Species
  • Human(1)
Tag
  • His Tag & Flag Tag(1)
Host
  • HEK293(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
SLC1A2
Human SLC1A2 Protein, Flag,His Tag (Detergent)
Human
HEK293
SDS-PAGE
ELISA

$805.00

20ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
[18F]RP-115[18F]RP-115Phase 2 ClinicalRio pharmaceuticals Inc
Alzheimer Disease; Dementia; Frontotemporal Dementia
Details
iQ-007iQ-007Phase 1 ClinicaliQure Pharma Inc
Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Neuralgia
Details
Customer Reviews